搜尋結果
What Rescheduling Marijuana Means For The Cannabis Industry
Forbes· 3 日前According to the Associated Press, the DEA has proposed moving marijuana from its current ...
Amgen Shares Soar on Obesity Drug Progress
Bloomberg· 7 小時前Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg ...
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is ...
Forbes· 16 小時前Skepticism may be warranted when the Centers for Medicare and Medicaid Services’ Office of the ...
Biden Administration Moving Marijuana To Less Severe Drug Class—Boosting Medical Uses, Reports ...
Forbes· 4 日前The Drug Enforcement Administration is reportedly planning to reclassify marijuana so it is no ...
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 2 日前Healthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their ...
Exclusive | TD Bank Probe Tied to Laundering of Illicit Fentanyl Profits
The Wall Street Journal· 1 日前The Canadian bank faces three other U.S. probes into its anti-money-laundering controls.
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 23 小時前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC· 7 小時前Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data ...
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Reuters· 11 小時前Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their ...
Rescheduling Marijuana Won’t Reduce Regulatory Confusion On Drug’s Use
Forbes· 2 日前... is getting one step closer to rescheduling marijuana, according to The Hill. The Drug& ... ...